ChemoMetec A/S (CHEMM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ChemoMetec A/S (CHEMM) has a cash flow conversion efficiency ratio of 0.139x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr90.64 Million ≈ $14.18 Million USD) by net assets (Dkr652.59 Million ≈ $102.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CHEMM market cap overview for the company's overall valuation and market capitalisation.
ChemoMetec A/S - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how ChemoMetec A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CHEMM live share price for real-time trading data and today's change.
ChemoMetec A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChemoMetec A/S ranked by their cash flow conversion efficiency. Review ChemoMetec A/S free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Capital Southwest Corporation
NASDAQ:CSWC
|
-0.076x |
|
Lotus Pharmaceutical Co Ltd
TW:1795
|
0.029x |
|
CCL Products (India) Limited
NSE:CCL
|
0.257x |
|
Hanall Biopharma
KO:009420
|
0.047x |
|
NV5 Global Inc
NASDAQ:NVEE
|
0.014x |
|
Adecoagro S.A
F:ACD
|
0.067x |
|
Advtech
JSE:ADH
|
0.311x |
|
FAP Agri Tbk PT
JK:FAPA
|
0.099x |
Annual Cash Flow Conversion Efficiency for ChemoMetec A/S (2005–2025)
The table below shows the annual cash flow conversion efficiency of ChemoMetec A/S from 2005 to 2025. Also see CHEMM total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | Dkr673.36 Million ≈ $105.35 Million |
Dkr207.45 Million ≈ $32.46 Million |
0.308x | +35.01% |
| 2024-06-30 | Dkr565.32 Million ≈ $88.45 Million |
Dkr129.00 Million ≈ $20.18 Million |
0.228x | -21.09% |
| 2023-06-30 | Dkr533.04 Million ≈ $83.40 Million |
Dkr154.15 Million ≈ $24.12 Million |
0.289x | -41.59% |
| 2022-06-30 | Dkr357.20 Million ≈ $55.89 Million |
Dkr176.86 Million ≈ $27.67 Million |
0.495x | +21.59% |
| 2021-06-30 | Dkr264.98 Million ≈ $41.46 Million |
Dkr107.90 Million ≈ $16.88 Million |
0.407x | +14.64% |
| 2020-06-30 | Dkr202.75 Million ≈ $31.72 Million |
Dkr72.02 Million ≈ $11.27 Million |
0.355x | +5.59% |
| 2019-06-30 | Dkr173.34 Million ≈ $27.12 Million |
Dkr58.31 Million ≈ $9.12 Million |
0.336x | -3.44% |
| 2018-06-30 | Dkr73.01 Million ≈ $11.42 Million |
Dkr25.44 Million ≈ $3.98 Million |
0.348x | +129.87% |
| 2017-06-30 | Dkr64.38 Million ≈ $10.07 Million |
Dkr9.76 Million ≈ $1.53 Million |
0.152x | -49.91% |
| 2016-06-30 | Dkr56.85 Million ≈ $8.89 Million |
Dkr17.20 Million ≈ $2.69 Million |
0.303x | +4.70% |
| 2015-06-30 | Dkr46.35 Million ≈ $7.25 Million |
Dkr13.39 Million ≈ $2.10 Million |
0.289x | +127.07% |
| 2014-06-30 | Dkr44.53 Million ≈ $6.97 Million |
Dkr5.67 Million ≈ $886.64K |
0.127x | -29.63% |
| 2013-06-30 | Dkr43.23 Million ≈ $6.76 Million |
Dkr7.82 Million ≈ $1.22 Million |
0.181x | -12.56% |
| 2012-06-30 | Dkr42.86 Million ≈ $6.71 Million |
Dkr8.87 Million ≈ $1.39 Million |
0.207x | +39.88% |
| 2011-06-30 | Dkr52.71 Million ≈ $8.25 Million |
Dkr7.79 Million ≈ $1.22 Million |
0.148x | +15.98% |
| 2010-06-30 | Dkr52.62 Million ≈ $8.23 Million |
Dkr6.71 Million ≈ $1.05 Million |
0.127x | -53.18% |
| 2009-06-30 | Dkr56.31 Million ≈ $8.81 Million |
Dkr15.33 Million ≈ $2.40 Million |
0.272x | +950.04% |
| 2008-06-30 | Dkr51.71 Million ≈ $8.09 Million |
Dkr1.34 Million ≈ $209.81K |
0.026x | +225.62% |
| 2007-06-30 | Dkr39.34 Million ≈ $6.15 Million |
Dkr-812.00K ≈ $-127.04K |
-0.021x | -170.06% |
| 2006-06-30 | Dkr16.50 Million ≈ $2.58 Million |
Dkr486.00K ≈ $76.04K |
0.029x | +18.05% |
| 2005-06-30 | Dkr-11.34 Million ≈ $-1.77 Million |
Dkr-283.00K ≈ $-44.28K |
0.025x | -- |
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, an… Read more